about
Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma.High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast.Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registrySorafenib inhibits many kinase mutations associated with drug-resistant gastrointestinal stromal tumors.Combination therapy for KIT-mutant mast cells: targeting constitutive NFAT and KIT activity.Gene expression of the IGF pathway family distinguishes subsets of gastrointestinal stromal tumors wild type for KIT and PDGFRA.KIT gene mutations and copy number in melanoma subtypes.
P50
Q33439741-6B6EFA1D-B550-4D1E-BBB8-0008EA27027AQ33515565-8E3E3267-30AC-403E-9C87-5C978E65FD1FQ35169273-99D957C0-B20F-46B6-9083-B52063F7FFBFQ38833725-3A6C4D7D-5C50-488A-83E9-C30415CDF0FBQ38953475-B32AD9CA-0052-4A48-ACFA-71571D0B4ECDQ42140883-8EF96DD8-4BEA-42EA-A4A8-3275C148D2F5Q46267082-8A924987-64C5-489F-95BA-D260DACBC812
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Janice Patterson
@ast
Janice Patterson
@en
Janice Patterson
@es
Janice Patterson
@nl
Janice Patterson
@sl
type
label
Janice Patterson
@ast
Janice Patterson
@en
Janice Patterson
@es
Janice Patterson
@nl
Janice Patterson
@sl
prefLabel
Janice Patterson
@ast
Janice Patterson
@en
Janice Patterson
@es
Janice Patterson
@nl
Janice Patterson
@sl
P106
P21
P31
P496
0000-0002-8969-2933
P569
2000-01-01T00:00:00Z